Bifidobacterium longum alleviates irritable bowel syndrome-related visceral hypersensitivity and microbiota dysbiosis via Paneth cell regulation

Although the oral administration of Bifidobacterium longum (B. longum) relieves the signs of irritable bowel syndrome (IBS) in clinical settings, the mechanisms underlying its effects are unclear. In this study, we evaluated the precise effects of B. longum on IBS via regulation of Paneth cell funct...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gut Microbes
Hlavní autoři: Zhou, Chunhua, Fang, Xue, Xu, Jiajia, Gao, Jun, Zhang, Ling, Zhao, Jiulong, Meng, Yuting, Zhou, Wei, Han, Xu, Bai, Yu, Li, Zhaoshen, Zou, Duowu
Médium: Artigo
Jazyk:Inglês
Vydáno: Taylor & Francis 2020
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7524277/
https://ncbi.nlm.nih.gov/pubmed/32584650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19490976.2020.1782156
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky